25 Apr Researchers Found Why CBD Affects Anxiety Differently in Each Person
SOURCE: IMAGE
Editor’s note: Cannabis and THCA/Hemp CBD products should have an active ingredient list on the container and a Certificate of Analysis (COA). Discuss your use of THC, cannabis, or CBD products with your health care provider. Dosing of cannabis products is variable, especially since they are not FDA regulated. Cannabis/CBD may interfere with other medications and should not be used in individuals with certain health conditions, including liver issues. CBD skin care products can be absorbed through the skin and have similar effects. Do not use cannabis products including edibles, drinks, and CBD if you are pregnant, nursing, or may become pregnant. Do not use cannabis products if driving or operating difficult or dangerous machinery. Children should not be exposed to cannabis or CBD products.
A question that comes up constantly in cannabis research is one that patients have been asking for years: why does CBD ease anxiety in one person and make another feel worse? For a long time, the honest answer was that nobody fully knew. A landmark study out of McGill University changedthat, and the findings reveal something that most consumer guides on CBD have never properly explained.
The answer is not about product quality, dosage form, or brand. It comes down to how cannabis interacts with serotonin — and specifically why that interaction is not the same at every dose.
What the McGill University Study Found
McGill University researchers found that cannabis boosts serotonin neuron activity at low doses and suppresses it at high doses — which is the core biological reason why the same product produces opposite emotional outcomes in different people.
The McGill research team, led by neuroscientist Dr. Gabriella Gobbi, set out to understand why cannabis has such inconsistent effects on mood and anxiety across the population. What they found was a double-edged sword in how THC interacts with the brain’s serotonin signaling system. At low doses, THC increases the firing rate of serotonin neurons in the dorsal raphe nucleus — the brain region responsible for regulating mood. At high doses, the same compound suppresses serotonin neuron activity, potentially worsening depression and anxiety rather than relieving it. The threshold between these two opposite effects varies from person to person, making dose prediction genuinely difficult.
This is the scientific explanation for something millions of cannabis users have experienced but never had language for: the same product that relaxes one person can send another into a spiral of anxiety, and both responses are pharmacologically real.
How Serotonin Connects Cannabis to Anxiety
The cannabis plant does not synthesize serotonin, but it affects the neurotransmitter activity of serotonin-producing neurons. This is why the impacts of cannabis on anxiety have been found to be highly dosage-dependent and person-specific.
Serotonin is not a molecule that cannabis produces or replenishes — understanding this distinction is important because it explains why cannabis does not work the same way as an SSRI antidepressant, even when the two share some overlapping effects on mood. What cannabis, specifically THC, does instead is interact with CB1 receptors present on serotonin-producing neurons. At low activation levels, this interaction appears to disinhibit serotonin neurons, allowing them to fire more freely. At higher activation levels, the effect reverses.
The result: low doses produce increased serotonin neuron firing, mood elevation, and reduced anxiety in many users, while high doses produce suppressed serotonin activity and increased risk of an anxious or depressive response. Baseline serotonin levels, CB1 receptor density, and genetic differences in cannabinoid metabolism all influence where that threshold sits for any given person.
The connection between CBD and anxiety differs somewhat from that between THC and anxiety. While CBD does not directly activate CB1 receptors as THC does, it has been found to have activity as a partial agonist at the 5-HT1A serotonin receptor — functioning similarly to buspirone. The evidence base in this area is still developing but growing consistently.
Why the Same Product Affects Two People Completely Differently
The McGill findings explain the mechanism, but the question of individual variability goes deeper than dose alone. Several factors shape how any one person responds to cannabis for anxiety.
Baseline serotonin levels. Someone with already-low serotonin activity may experience a more pronounced mood-lifting effect at low doses, while someone with normal or elevated baseline levels may feel little change or increased anxiety.
CB1 receptor density. Genetic differences may cause differences in the number of CB1 receptors expressed and their sensitivity, resulting in a different dose threshold for the biphasic response.
Metabolism speed. CYP2C9 enzyme variants affect how quickly THC is broken down in the body. Slow metabolizers accumulate higher blood concentrations from the same dose, pushing them past the therapeutic window faster.
Tolerance and prior exposure. Regular cannabis use leads to downregulation of CB1 receptors, which means an identical dose used previously to create a calming effect may need adjustment to maintain the same impact.
Anxiety subtype. Generalized anxiety disorder, social anxiety, and PTSD all involve different neurobiological profiles, and the evidence for cannabis across these subtypes is not uniform.
What This Means for People Considering Cannabis for Anxiety
The McGill serotonin findings give a clear neurobiological reason why starting at the lowest possible dose and increasing slowly is the only rational approach to using cannabis for anxiety. The research does not say that cannabis works for anxiety or that it does not — it says the relationship is dose-dependent, individually variable, and mediated by serotonin in a way that most consumer-facing content does not accurately reflect.
For adults considering cannabis for anxiety: start at the lowest available dose and wait at least 90 minutes before considering additional intake for edibles. CBD-dominant products that engage the 5-HT1A pathway without significant THC may carry a lower risk of triggering the suppressive end of the biphasic response. Full-spectrum products that include both CBD and low-dose THC have a different receptor profile than isolate products and may produce different anxiety outcomes in the same individual. Discussing cannabis use with a physician is particularly important for anyone already on SSRIs, SNRIs, or other serotonergic medications, given the interaction risks documented in the literature.
For residents of Sacramento County, weed delivery Rocklin and the surrounding areas is available through NorCal Holistics, a licensed service carrying lab-tested, state-compliant products.
Frequently Asked Questions
Why does cannabis make some people feel anxious instead of calm?
Cannabis has a biphasic effect on serotonin neurons — boosting them at low doses and suppressing them at high doses. When a user exceeds their individual threshold, the response reverses from calming to anxiety-producing, according to the McGill University research.
Does CBD affect serotonin the same way THC does?
No. THC mediates serotonin through CB1 receptors, while CBD works as a partial agonist of the 5-HT1A serotonin receptor — a mechanism that resembles some prescription anxiety medications.
Is there a safe dose of cannabis for anxiety?
There is no single safe dosage because the range of efficacy differs from person to person. Scientists and medical practitioners advise starting with 2.5 mg THC or below and gradually increasing over days.
Can cannabis interact with antidepressants?
Yes. Case studies recorded in peer-reviewed literature describe patients who experienced serotonin syndrome after using cannabis alongside SSRIs. Anyone taking antidepressants must consult their doctor about cannabis use.
What does the 5-HT1A receptor have to do with anxiety?
The 5-HT1A serotonin receptor regulates anxiety and stress response and is the primary target of buspirone, a prescription anti-anxiety medication. Research by Russo et al. published in Neuropsychopharmacology in 2005 identified cannabidiol as a partial agonist at this receptor, providing the first mechanistic explanation for why CBD produces anxiolytic effects independently of the CB1 system.
Conclusion
The McGill University study may not provide final closure on the cannabis and anxiety connection, but it provides a clear neurobiological framework for understanding it. The reason why cannabis produces two opposite results in terms of anxiety lies in the dual nature of THC’s effect on serotonin, coupled with real individual differences in biology and metabolism.
That is not a flaw in the research — it is the research. And it points toward a more individualized, lower-dose approach to cannabis for anxiety that is increasingly supported by the evidence building in this field.
- If you or someone you know is struggling or in crisis, help is available. Call or text 988 or chat at org. To learn how to get support for mental health, drug or alcohol conditions, visit FindSupport.gov. If you are ready to locate a treatment facility or provider, you can go directly to FindTreatment.govor call 800-662-HELP (4357).
- U.S. veterans or service members who are in crisis can call 988 and then press “1” for the Veterans Crisis Line. Or text 838255. Or chat online.
- The Suicide & Crisis Lifeline in the U.S. has a Spanish language phone line at 1-888-628-9454 (toll-free).
Disclaimer: The information on MedicalResearch.com is provided for educational purposes only, and is in no way intended to diagnose, cure, or treat any medical or other condition. Some links are sponsored. Products, services and providers are not warranted or endorsed by MedicalResearch.com or Eminent Domains Inc. Always seek the advice of your physician or other qualified health and ask your doctor any questions you may have regarding a medical condition. In addition to all other limitations and disclaimers in this agreement, service provider and its third party providers disclaim any liability or loss in connection with the content provided on this website.
Last Updated on April 25, 2026 by Marie Benz MD FAAD